DoxyPEP Tied to Decreases in Sexually Transmitted Infections
By Lori Solomon HealthDay Reporter
TUESDAY, Jan. 7, 2025 -- Doxycycline postexposure prophylaxis (doxyPEP) initiation is associated with decreases in sexually transmitted infections (STIs), according to a study published online Jan. 6 in JAMA Internal Medicine.
Michael W. Traeger, Ph.D., from Harvard Pilgrim Health Care Institute in Boston, and colleagues described early uptake of doxyPEP and evaluated changes in STI incidence following doxyPEP initiation. The analysis included data from 11,551 adults dispensed HIV preexposure prophylaxis (PrEP) at Kaiser Permanente Northern California from Nov. 1, 2022, to Dec. 31, 2023.
The researchers found that 19.5 percent were dispensed doxyPEP, which was associated with older age (mean age, 40.4 versus 39.8 years), longer HIV PrEP use (mean, 4.2 versus 3.4 years), and a higher proportion of commercial insurance (92.8 versus 88.9 percent). Quarterly chlamydia positivity decreased from 9.6 percent before starting doxyPEP to 2.0 percent after starting doxyPEP (rate ratio [RR], 0.21), with significant declines for each anatomic site of infection. Similarly, quarterly gonorrhea positivity decreased from 10.2 percent before starting doxyPEP to 9.0 percent afterward (RR, 0.88), with significant site-specific declines seen for rectal (RR, 0.81) and urethral (RR, 0.56) gonorrhea. Lastly, quarterly syphilis positivity decreased from 1.7 percent before starting doxyPEP to 0.3 percent afterward (RR, 0.20). Among individuals not dispensed doxyPEP, positivity for STIs remained stable.
"These findings suggest that doxyPEP may offer substantial benefits for reducing population-level STI transmission with broader implementation," the authors write.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Prior Military Sexual Trauma Linked to Late-Life Suicide Attempt
THURSDAY, May 1, 2025 -- Prior military sexual trauma (MST) is associated with late-life suicide attempt and death by suicide or overdose, according to a study published online...
Antibiotic Noninferior to Ceftriaxone + Azithromycin for Gonorrhea
MONDAY, April 21, 2025 -- For uncomplicated urogenital gonorrhea, gepotidacin, which inhibits bacterial DNA replication, is noninferior to ceftriaxone plus azithromycin, according...
Treating Male Partners Reduces Recurrence in Bacterial Vaginosis
MONDAY, March 10, 2025 -- Treating male partners in addition to women with bacterial vaginosis results in a lower rate of recurrence than treating only women, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.